NHS England risks missing cancer treatment target by nearly 10000 patients
NHS England is on track to miss its March 2027 cancer target by nearly 10,000 patients unless monthly treatment numbers increase significantly, according to reports.
FTMQ News, written by our newsroom1 view

NHS England is set to miss its key cancer target, leaving nearly 10,000 patients in England without timely care, The Guardian and UA.NEWS reported. Experts warned that the shortfall is driven by a lack of leadership, focus, and resources across the health service. [1][2]
The interim NHS goal requires 80 percent of cancer patients to begin treatment within 62 days of an urgent referral or consultant upgrade by March 2027. According to The Guardian, an additional 2,850 patients a month must start treatment within that timeframe to reach the target, but progress remains slow with little more than 100 days remaining. [1]
NHS England operates as an executive non-departmental public body under the Department of Health and Social Care, overseeing the budget and day-to-day operation of commissioning for the National Health Service in England. With a budget that has exceeded 170 billion pounds in recent years, the organisation directly commissions specialized services and primary care while managing funding for integrated care boards. [3][4]
In short
- NHS England is projected to miss its interim cancer treatment target by nearly 10,000 patients.
- Meeting the March 2027 goal requires an additional 2,850 patients per month to start care within 62 days.
- The target mandates that 80 percent of cancer patients begin treatment within 62 days of urgent referral or upgrade.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]NHS England on track to miss key cancer treatment target by 10,000 patientsThe Guardian, 2d ago (the report this story comes from)
- [2]NHS England risks failing to start treatment on time for 10,000 cancer patients — The GuardianUA.NEWS, 2d ago
Background
- [3]NHS England on Wikipedia
- [4]NHS England on Grokipedia
- [5]Stopping GLP1 diabetes drugs doubles risk of heart attack and stroke FTMQ News, 5d ago
- [6]DR Congo treatment centre discharges last confirmed Ebola patients in Ituri FTMQ News, 18d ago
Our newsroom writes these reports with the help of software, from the 6 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from FTMQ News
Earlier reports of ours on the same people and subjects.
- Brain scanner shortage risks dementia care in the UKTop Stories, 13h ago
- NHS England issues updated guidance on trans patients and single sex wardsTop Stories, 32d ago
- Almost half of NHS trusts in England lack earmarked maternity fundsTop Stories, 8d ago
- England introduces new early warning system for sick children in emergency departmentsTop Stories, 15d ago
- Health secretary orders urgent plan to stop hospital corridor care for childrenTop Stories, 29d ago
More in Top Stories
- Fiona the hippo under veterinary care after swallowing hat in Cincinnati17m ago
- UK government plans to remove failed asylum seekers without notice18m ago
- Crew of HMS Vengeance speak after record submarine deployment18m ago
- Curt Cignetti rejects critics of Indiana football schedule and opposing coach18m ago
- Russian strikes hit two major Kyiv bridges and disrupt utilities37m ago
- California woman born without limbs loses independence after specialized van breaks37m ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.


Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.